Safety and efficacy of tocotrienol supplementation for bone health in postmenopausal women: protocol for a dose-response double-blinded placebo-controlled randomised trial

Chwan-Li Shen, Huanbiao Mo, Shengping Yang, Shu Wang, Carol K Felton, Michael D Tomison, Ima Nirwana Soelaiman, Chwan-Li Shen, Huanbiao Mo, Shengping Yang, Shu Wang, Carol K Felton, Michael D Tomison, Ima Nirwana Soelaiman

Abstract

Introduction: Osteoporosis is a major health concern in postmenopausal women, and oxidative stress contributes to the development of bone loss. Cellular studies and ovariectomised rat model mimicking bone loss in postmenopausal women show the bone-protective effect of tocotrienols (TTs) with antioxidant capability. We aim to access the safety and efficacy of TT consumption for bone health in postmenopausal women.

Methods and analysis: In this 12-week randomised double-blinded placebo-controlled trial for the effects of dietary TT supplementation in postmenopausal women, postmenopausal women aged 45 years and older with at least 1 year after menopause and bone mineral density T-score at the spine and/or hip 2.5 or more below the reference values will be randomly assigned to 3 daily supplements: (1) placebo group receiving 860 mg olive oil, (2) low TT group receiving 430 mg of 70% pure TTs (containing 300 mg TT) and (3) high TT group receiving 860 mg of 70% pure TTs (600 mg TT). The primary outcome measure will be urinary N-terminal telopeptide. The secondary outcome measures will be serum bone-specific alkaline phosphatase, receptor activator of nuclear factor-κB ligand, osteoprotegerin, urinary 8-hydroxy-2'-deoxyguanosine and quality of life. At 0, 6 and 12 weeks, the following will be assessed: (1) primary and secondary outcome measures; (2) serum TT and tocopherol concentrations; (3) physical activity and food frequency questionnaires. Liver function will be monitored every 6 weeks for safety. 'Intent-to-treat' principle will be employed for data analysis. A model of repeated measurements with random effect error terms will be applied. Analysis of covariance, χ2 analysis and regression will be used for comparisons.

Ethics and dissemination: This study was approved by the Bioethics Committee of the Texas Tech University Health Sciences Center. The findings of this trial will be submitted to a peer-reviewed journal in the areas of bone or nutrition and international conferences.

Trial registration number: NCT02058420; results.

Keywords: bone turnover marker; intervention trial; osteoporosis; oxidative stress; tocotrienols; women.

Conflict of interest statement

This study is funded by American River Nutrition.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

References

    1. NIH. Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95.
    1. Looker AC, Melton LJ III, Harris TB et al. . Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J Bone Miner Res 2010;25:64–71. 10.1359/jbmr.090706
    1. World Health Organization. Assessment of fracture risk and application to screening for postmenopausal osteoporosis. WHO Technical Report Series Geneva, Switzerland: World Health Organization, 1994:843.
    1. National Osteoporosis Foundation. American's bone health: the state of osteoporosis and low bone mass in our nation. Washington DC: National Osteoporosis Foundation, 2002:1–55.
    1. Miller LJ III, Crowson CS, O'Fallon WM et al. . Relative contributions of bone density, bone turnover, and clinical risk factors to long-tern fracture prediction. J Bone Miner Res 2003;18:312–18. 10.1359/jbmr.2003.18.2.312
    1. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass predictors of fracture in a prospective study. J Clin Invest 1988;81:1804–9. 10.1172/JCI113523
    1. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measurements of bone mineral density predict the occurrence of osteoporotic fractures. BMJ 1996;312:1254–9.
    1. Vasikaran S, Eastell R, Bruyère O et al. . IOF-IFCC Bone Marker Standards Working Group: markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22:391–420. 10.1007/s00198-010-1501-1
    1. Worsfold M, Powell DE, Jones TJ et al. . Assessment of urinary bone markers for monitoring treatment of osteoporosis. Clin Chem 2004;50:2263–70. 10.1373/clinchem.2004.037424
    1. Arjmandi BH, Khalil DA, Smith BJ et al. . Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003;88:1048–54. 10.1210/jc.2002-020849
    1. Lucas EA, Wild RD, Hammond LJ et al. . Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002;87:1527–32. 10.1210/jcem.87.4.8374
    1. Adachi JD. The correlation of bone mineral density and biochemical markers to fracture risk. Calcif Tissue Int 1996;59(Suppl I):S16–9.
    1. Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996;17:333–68. 10.1210/edrv-17-4-333
    1. Lofman O, Magnusson P, Toss G et al. . Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta 2005;356:67–75. 10.1016/j.cccn.2004.12.014
    1. Basu S, Michaëlsson K, Olofsson H et al. . Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001;288:275–9. 10.1006/bbrc.2001.5747
    1. Banfi G, Iorio EL, Corsi MM. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008;46:1550–5. 10.1515/CCLM.2008.302
    1. Ha H, Lee JH, Kim HN et al. . Alpha-tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity. Biochem Biophys Res Commun 2011;406:546–51. 10.1016/j.bbrc.2011.02.085
    1. Nizar AM, Nazrun AS, Norazlina M et al. . Low dose of tocotrienols protects osteoblasts against oxidative stress. Clin Ter 2011;162:533–8.
    1. Brooks R, Kalia P, Ireland DC et al. . Direct inhibition of osteoclast formation and activity by the vitamin E isomer gamma-tocotrienol. Int J Vitam Nutr Res 2011;81:358–67. 10.1024/0300-9831/a000087
    1. Abd Manan N, Mohamed N, Shuid AN. Effects of low-dose versus high-dose γ-tocotrienol on the bone cells exposed to the hydrogen peroxide-induced oxidative stress and apoptosis. Evid Based Complement Alternat Med 2012;2012:680834 10.1155/2012/680834
    1. Abdul-Majeed S, Mohamed N, Soelaiman IN. The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy. Life Sci 2015;125:42–8. 10.1016/j.lfs.2014.12.012
    1. Ima-Nirwana S, Suhaniza S. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J Med Food 2004;7:45–51. 10.1089/109662004322984699
    1. Ahmad NS, Khalid BA, Luke DA et al. . Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol 2005;32:761–70. 10.1111/j.1440-1681.2005.04264.x
    1. Norazlina M, Ng FW, Ima-Nirwana S. γ-tocotrienol is required for normal vitamin D metabolism in female rats. Indian J Pharmacol 2005;37:309–14.
    1. Hermizi H, Faizah O, Ima-Nirwana S et al. . Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in sprague-dawley male rats after nicotine cessation. Calcif Tissue Int 2009;84:65–74. 10.1007/s00223-008-9190-x
    1. Mehat MZ, Shuid AN, Mohamed N et al. . Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats. J Bone Miner Metab 2010;28:503–9. 10.1007/s00774-010-0159-2
    1. Mohamad S, Shuid AN, Mokhtar SA et al. . Tocotrienol supplementation improves late-phase fracture healing compared to alpha-tocopherol in a rat model of postmenopausal osteoporosis: a biomechanical evaluation. Evid Based Complement Alternat Med 2012;2012:372878 10.1155/2012/372878
    1. Norazlina M, Hermizi H, Faizah O et al. . Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in Male rats. Arch Med Sci 2010;6:505–12. 10.5114/aoms.2010.14460
    1. Chin KY, Abdul-Majeed S, Fozi NF et al. . Annatto tocotrienol improves indices of bone static histomorphometry in osteoporosis due to testosterone deficiency in rats. Nutrients 2014;6:4974–83. 10.3390/nu6114974
    1. Abdul-Majeed S, Mohamed N, Soelaiman IN. Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Alternat Med 2012;2012:960742 10.1155/2012/960742
    1. Chin KY, Ima-Nirwana S. Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats. Clin Interv Aging 2014;9:1247–59. 10.2147/CIA.S67016
    1. Muhammad N, Luke DA, Shuid AN et al. . Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study. Clinics (Sao Paulo). 2013;68:1338–43. 10.6061/clinics/2013(10)08
    1. Muhammad N, Luke DA, Shuid AN et al. . Two different isomers of vitamin e prevent bone loss in postmenopausal osteoporosis rat model. Evid Based Complement Alternat Med 2012;2012:161527 10.1155/2012/161527
    1. Maggio D, Barabani M, Pierandrei M et al. . Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003;88:1523–7. 10.1210/jc.2002-021496
    1. Michaëlsson K, Wolk A, Byberg L et al. . Intake and serum concentrations of α-tocopherol in relation to fractures in elderly women and men: 2 cohort studies. Am J Clin Nutr 2014;99:107–14.
    1. Mata-Granados JM, Cuenca-Acebedo R, Luque de Castro MD et al. . Lower vitamin E serum levels are associated with osteoporosis in early postmenopausal women: a cross-sectional study. J Bone Miner Metab 2013;31:455–60. 10.1007/s00774-013-0432-2
    1. Ruiz-Ramos M, Vargas LA, Fortoul et al. . Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly. J Nutr Health Aging 2010;14:467–72.
    1. Hamidi MS, Corey PN, Cheung AM. Effects of vitamin E on bone turnover markers among us postmenopausal women. J Bone Miner Res 2012;27:1368–80. 10.1002/jbmr.1566
    1. Wolf RL, Cauley JA, Pettinger M et al. . Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am J Clin Nutr 2005;82:581–8.
    1. Ochi H, Takeda S. The two sides of vitamin E supplementation. Gerontology 2015;61:319–26. 10.1159/000366419
    1. Garrett IR, Boyce BF, Oreffo ROC et al. . Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990;85:632–9. 10.1172/JCI114485
    1. Dreher I, Schuetze N, Baur A et al. . Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 1998;245:101–7. 10.1006/bbrc.1998.8393
    1. Hopewell S, Clarke M, Moher D et al. , CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008;5:e20 10.1371/journal.pmed.0050020
    1. Iwamoto J, Takada T. Effect of minodronate on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: a clinical practice-based observational study. J Chin Med Assoc 2015;78:591–6. 10.1016/j.jcma.2015.06.010
    1. Kanders B, Dempster DW, Lindsay R. Interaction of calcium nutrition and physical activity on bone mass in young women. J Bone Miner Res 1988;3:145–9. 10.1002/jbmr.5650030204
    1. Jackson LW, Cromer BA, Panneerselvamm A. Association between bone turnover, micronutrient intake, and blood lead levels in pre- and postmenopausal women, NHANES 1999–2002. Environ Health Perspect 2010;118:1590–6. 10.1289/ehp.1002158
    1. Shen CL, Chyu MC, Yeh JK et al. . Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial. Osteoporos Int 2012;23:1541–52. 10.1007/s00198-011-1731-x
    1. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659–61. 10.1096/fj.07-9574LSF
    1. Mahipal A, Klapman J, Vignesh S et al. . Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites. Cancer Chemother Pharmacol 2016;78:157–65. 10.1007/s00280-016-3048-0
    1. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
    1. Pickard AS, Johnson JA, Penn A et al. . Replicability of SF-36 summary scores by the SF-12 in stroke patients. Stroke 1999;30:1213–7.
    1. Ware J, Snow KK, Kosinski M. SF-36 health survey manual and interpretation guide. Boston, MA: Health Institute, New England Medical Center Hospital, 1993.
    1. Yamazaki S, Ichimura S, Iwamoto J et al. . Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis. J Bone Miner Metab 2004;22:500–8. 10.1007/s00774-004-0514-2
    1. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005;90:6323–31. 10.1210/jc.2005-0794
    1. Marques EA, Mota J, Viana JL et al. . Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. Arch Gerontol Geriatr 2013;57:226–33. 10.1016/j.archger.2013.03.014
    1. Josse AR, Atkinson SA, Tarnopolsky MA et al. . Diets higher in dairy foods and dietary protein support bone health during diet- and exercise-induced weight loss in overweight and obese premenopausal women. J Clin Endocrinol Metab 2012;97:251–60. 10.1210/jc.2011-2165
    1. Dawson-Hughes B, Harris SS, Palermo NJ et al. . Potassium bicarbonate supplementation lowers bone turnover and calcium excretion in older men and women: a randomized dose-finding trial. J Bone Miner Res 2015;30:2103–11. 10.1002/jbmr.2554
    1. Kanellakis S, Moschonis G, Tenta R et al. . Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II. Calcif Tissue Int 2012;90:251–62. 10.1007/s00223-012-9571-z
    1. Steenken S. Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e-and OH adduct. Chem Rev 1989;89:503–20.
    1. Kasai H, Yamaizumi Z, Yamamoto F et al. . Photosensitized formation of 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in DNA by riboflavin. Nucleic Acids Symp Ser 1992;27: 181–2.
    1. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004;567:1–61. 10.1016/j.mrrev.2003.11.001
    1. Pilger A, Germadnik D, Riedel K et al. . Longitudinal study of urinary 8-hydroxy-2-deoxyguanosine excretion in healthy adults. Free Radic Res 2001;35:273–80.
    1. Grebenstein N, Frank J. Rapid baseline-separation of all eight tocopherols and tocotrienols by reversed-phase liquid-chromatography with a solid-core pentafluorophenyl column and their sensitive quantification in plasma and liver. J Chromatogr A 2012;1243:39–46. 10.1016/j.chroma.2012.04.042

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する